| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3128376 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as condensed nucleus in tumor cells at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA3128377 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as DNA fragmentation in tumor cells at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA3128378 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as formation of apoptotic bodies in tumor cells at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth by Giemsa staining | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA3128379 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as membrane blebbing of tumor cells at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth by Giemsa staining | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA3128380 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as irregular tumor cell shape at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth by Giemsa staining | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA3128381 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as tumor cell shrinkage at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA3128382 | F | Ex vivo antiangiogenic activity in 2 days fertilized chicken embryo chorioallantoic membrane model assessed as inhibition of rVEGF165-induced angiogenesis at 10 uM after 72 hrs by photographic analysis relative to control | Gallus gallus | 1 | tissue-based format | Scientific Literature | ||
| 8. | ALA3128383 | F | In vivo antiangiogenic activity in 12 days fertilized chicken embryo chorioallantoic membrane model assessed as inhibition of rVEGF165-induced angiogenesis at 10 uM by photographic analysis relative to control | Gallus gallus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA3128384 | F | Antiangiogenic activity in mouse EAC cells allografted Swiss albino mouse model assessed as decrease in microvessel density in peritoneum at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth by hematoxylin and eosin staining method | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA3128385 | F | Antiangiogenic activity in mouse EAC cells allografted Swiss albino mouse model assessed as decrease in peritoneal angiogenesis at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA3128386 | T | Toxicity in Swiss albino mouse assessed as WBC count at 75 mg/kg, ip administered for 10 days (Rvb = 3.22 +/- 1.2 x 10'6/microL) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA3128387 | T | Toxicity in Swiss albino mouse assessed as RBC count at 75 mg/kg, ip administered for 10 days (Rvb = 5.18 +/- 1.45 x 10'6/microL) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA3128388 | T | Toxicity in Swiss albino mouse assessed as urea level at 75 mg/kg, ip administered for 10 days (Rvb = 42 +/- 2.78 mg/dl) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA3128389 | T | Toxicity in Swiss albino mouse assessed as creatinine level at 75 mg/kg, ip administered for 10 days (Rvb = 0.59 +/- 1.05 mg/dl) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA3128390 | T | Toxicity in Swiss albino mouse assessed as alkaline phosphatase level at 75 mg/kg, ip administered for 10 days (Rvb = 128.55 +/- 2.55 IU/L) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA3128391 | T | Toxicity in Swiss albino mouse assessed as change in liver morphology at 75 mg/kg, ip administered for 10 days relative to untreated control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA3128392 | T | Toxicity in Swiss albino mouse assessed as change in spleen morphology at 75 mg/kg, ip administered for 10 days relative to untreated control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA3128393 | F | Antitumor activity against mouse DLA cells allografted in Swiss albino mouse assessed as tumor regression at 75 mg/kg, ip administered alternate days total of 10 doses measured on day 35 relative to untreated control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA3128394 | F | Antitumor activity against mouse EAC cells allografted in Swiss albino mouse assessed as inhibition of tumor growth at at 75 mg/kg, ip 3 doses administered every alternate days after three days of tumor growth | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA3128427 | F | Antitumor activity against ip dosed mouse EAC cells allografted in Swiss albino mouse assessed as decrease in body weight administered 3 doses every alternate days after three days of tumor growth | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!